MedTrace Logo

Multiple Algorithms System Of All Scores in Embolism (MOSE)

NCT02911012 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 15208

Last updated 2016-11-28

No results posted yet for this study

Summary

The aim of this study is to overcome the current limits of the scoring systems used to predict both the thrombotic (VTE) and hemorrhagic (BLD) risk for the patient. The main problem of these scoring systems is due to the high rigidity related to the score assigned at each risk item. The presence of an item assigns the full score for that item, without the possibility to moderate that item's score. The final class of risk, for the patient, is the sum of the scores of the selected items. The approach used for the assessment is based on the presence or absence of certain items that will be summed.

Starting from scoring system currently used for VTE (PADUA, CAPRINI, KHORANA) and also for BLD (IMPROVE), we will integrate all common items in a single scoring system managed by risk management algorithms that can identify the different classes of risk.

Conditions

  • Venous Thromboembolism
  • Risk Assessment
  • Risk Management

Sponsors & Collaborators

  • University Magna Graecia

    lead OTHER

Principal Investigators

  • Stefano de Franciscis, M.D. · University Magna Graecia of Catanzaro

  • Raffaele Serra, M.D., PhD. · University Magna Graecia of Catanzaro

  • Matteo Di Minno, M.D., PhD · Federico II University

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2016-10-31
Primary Completion
2017-04-30
Completion
2017-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02911012 on ClinicalTrials.gov